Which drug classification would the nurse expect a client newly diagnosed with a duodenal ulcer to be prescribed?

Duodenal ulcers are primarily managed by suppressing gastric acid to allow the mucosal lining to regenerate. Proton pump inhibitors are the gold standard for this purpose, as they provide superior acid inhibition compared to other agents. By irreversibly inhibiting the H+/K+ ATPase enzyme system, these drugs create an alkaline environment conducive to rapid epithelial repair. A. A laxative with a stool softener: These agents are utilized to treat constipation by increasing fecal bulk or facilitating moisture penetration into the stool. They have no physiological effect on gastric acid production or the healing of duodenal erosions. Their use is unrelated to the treatment of peptic ulcer disease. B. An over-the-counter antacid: While antacids provide transient relief by neutralizing existing hydrochloric acid, they do not provide the sustained acid suppression required for ulcer healing. They are used for symptomatic breakthrough pain rather than as a primary curative treatment. Their effect is too brief for effective tissue remodeling. C. A proton pump inhibitor: PPIs, such as omeprazole or pantoprazole, significantly reduce the volume and acidity of gastric secretions over a 24-hour period. This profound hypochlorhydria is essential for the stabilization of clots and the resolution of inflammatory lesions in the duodenum. They are the most effective class for long-term management. D. A phenothiazine: This class of drugs, including prochlorperazine, is primarily used for its antipsychotic or antiemetic properties. They do not influence the secretory pathways of parietal cells or contribute to the healing of peptic ulcers. Their mechanism of action involves dopamine receptor blockade in the brain.